Exhibitor Tutorial
Ashok Bandaranayake
Dir. Bioprocess Development
Optide Program, Fred Hutch Cancer Center
Jonas Angstenberger
Senior Scientist II - Head of Process Automation & Data Science
AbbVie Deutschland GmbH & Co. KG
Learn from cutting-edge experts how they have automated biotherapeutic workflows, including one end to end solution that captures sample preparation and HPLC detection, and synthetic biology workflows using Thermo Scientific Momentum automation solutions. Hot buffet lunch provided!
Automating Biotherapeutic and Synthetic Biology Workflows
Monday, February 5
12:30 PM – 1:45 PM
A compact and versatile automation platform for nucleic acid isolation and assay setup
Tuesday, February 6
9:30 AM – 10:15 AM
Rapid deployment laboratory automation
Tuesday, February 6
11:30 AM – 11:50 AM
Dir. Bioprocess Development
Optide Program, Fred Hutch Cancer Center
Dr. Bandaranayake earned his undergraduate degree in biochemistry (UC Davis) and his PhD in immunology (University of Washington, Seattle) in order to achieve his goal of developing therapeutics. He was introduced to automation at Albert Einstein College of Medicine where he was a Faculty member working for the New York Structure Consortium and immediately saw the power of harnessing automation in the drug discovery and development process. He then moved to the Fred Hutch to design and develop his own automated pipeline for protein production, antibody development and immuno-oncology assays.
Automating Biotherapeutic and Synthetic Biology Workflows
Monday, February 5
12:30 PM – 1:45 PM
Senior Scientist II - Head of Process Automation & Data Science
AbbVie Deutschland GmbH & Co. KG
Jonas Angstenberger studied biology and finished his PH.D. in basic medical research at the Max Planck Institute of Biochemistry / University of Constance. His first position in the pharmaceutical industry was a two year trainee program in drug development at AbbVie. During the trainee program in DMPK, Bioanalysis, QA and New Biological Entities (NBE) in Germany and the US he focused on automation and data handling. In 2016 he took over the newly formed group within the NBE formulation department responsible for automation and data science. He is focusing on implementing the fully integrated automation line evolving it to intelligent automation by combining automation with new concepts of data handling.
Automating Biotherapeutic and Synthetic Biology Workflows
Monday, February 5
12:30 PM – 1:45 PM
Dr. William Streyer is the manager of the iBioFAB (Illinois Biological Foundry for Advanced Biomanufacturing) laboratory automation facility at the Carl R. Woese Institute for Genomic Biology at the University of Illinois in Champaign-Urbana. He graduated with a B.S. in Mathematics from the University of South Carolina and an M.S. and Ph.D. in electrical engineering from the University of Illinois. The iBioFAB is an integrated robotic biological foundry that has been used to automate: combinatorial DNA assembly, yeast genome engineering, pathway optimization in bacteria, honeybee larvae rearing, and much more ahead.
Automating Biotherapeutic and Synthetic Biology Workflows
Monday, February 5
12:30 PM – 1:45 PM
The asset you are trying to access is locked. Please enter your access key to unlock.